Senior Medical Director
CurrentReplimune is a clinical-stage biotech that develops the next generation of oncolytic immunotherapies for the treatment of solid tumor (Cutaneous Squamous Cell Cancer, NSCLC and Melanoma)Worked as medical director and medical monitor managing global trials / First in human and Phase 2 in patients with solid tumor investigating oncolytic virus using intra-tumoral injections and anti- PD1 (MAB, immune checkpoint inhibitors). Provided input to Clinical Development plan. Lead activities with BLA/IND submission.